• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2400349 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2024-07-09 Bristol-Myers Squibb Pharma Eeig;Patheon Inc view
JYHB2002749 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2021-01-01 Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp Filed 2021-01-22 view
JYHB1901276 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2019-11-06 Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp Certificate Issued 2020-02-18 view
JYHB1400824 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2014-06-27 Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Company Certificate Issued 2015-01-27 view
CYHS2403436 达沙替尼片 dasatinib Tablet Chemical Drugs(4) Generic Drug 2024-10-13 Beijing SL Pharmaceutical Co Ltd view
JYHS2300020 达沙替尼片 dasatinib Tablet Chemical Drugs(5.2) Import Drug Application 2023-02-13 Dr Reddy's Laboratories Ltd;Kunshan Rotam Reddy Pharmaceutical Co Ltd view
JYHB2000239 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2020-03-21 Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp Certificate Issued 2020-04-23 view
CYHB2400893 达沙替尼片 dasatinib Tablet Chemical Drugs(原6) Supplementary Application 2024-06-26 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
JYHB2001257 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2020-08-05 Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp Filed 2020-08-17 view
JYHB1501088 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2015-08-12 Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Company Certificate Issued 2016-06-01 view
JYHB2400523 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2024-10-09 Bristol-Myers Squibb Pharma Eeig;Patheon Inc view
JYHB2200233 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2022-04-24 Bristol-Myers Squibb Pharma Eeig;Patheon Inc view
JYHZ2500026 达沙替尼片 dasatinib Tablet Chemical Drugs License Renew 2025-02-07 Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc view
CYHS2301250 达沙替尼片 dasatinib Tablet Chemical Drugs(4) Generic Drug 2023-05-09 Qilu Pharmaceutical (Hainan) Co Ltd view
JYHZ2000109 达沙替尼片 dasatinib Tablet Chemical Drugs License Renew 2020-05-23 Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp Certificate Issued 2020-10-13 view
JYHB1901275 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2019-11-06 Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp Certificate Issued 2020-02-18 view
JYHB1400823 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2014-06-27 Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Company Certificate Issued 2015-01-27 view
CYHS2403437 达沙替尼片 dasatinib Tablet Chemical Drugs(4) Generic Drug 2024-10-13 Beijing SL Pharmaceutical Co Ltd view
JYHS2300019 达沙替尼片 dasatinib Tablet Chemical Drugs(5.2) Import Drug Application 2023-02-13 Dr Reddy's Laboratories Ltd;Kunshan Rotam Reddy Pharmaceutical Co Ltd view
JYHB2000241 达沙替尼片 dasatinib Tablet Chemical Drugs Supplementary Application 2020-03-21 Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp Certificate Issued 2020-04-23 view